EssilorLuxottica (OTCMKTS:ESLOY) Sees Strong Trading Volume – Here’s Why

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) shares saw strong trading volume on Thursday . 331,646 shares were traded during trading, an increase of 201% from the previous session’s volume of 110,267 shares.The stock last traded at $136.59 and had previously closed at $138.50.

Analysts Set New Price Targets

A number of brokerages have commented on ESLOY. Citigroup reissued a “buy” rating on shares of EssilorLuxottica in a report on Thursday, December 11th. The Goldman Sachs Group reiterated a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Thursday, January 15th. Royal Bank Of Canada restated an “outperform” rating on shares of EssilorLuxottica in a report on Tuesday, October 28th. Finally, Zacks Research lowered shares of EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Buy”.

EssilorLuxottica Stock Performance

The firm has a fifty day moving average of $157.26 and a 200-day moving average of $163.39. The company has a current ratio of 0.97, a quick ratio of 0.67 and a debt-to-equity ratio of 0.18.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.